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A B S T R A C T
Background
Surgery performed to improve or replace the function of the diseased urinary bladder has been carried out for over a century. Main
reasons for improving or replacing the function of the urinary bladder are bladder cancer, neurogenic bladder dysfunction, detrusor
overactivity and chronic inflammatory diseases of the bladder (such as interstitial cystitis, tuberculosis and schistosomiasis). There is still
much uncertainty about the best surgical approach. Options available at the present time include: (1) conduit diversion (the creation of
various intestinal conduits to the skin) or continent diversion (which includes either a rectal reservoir or continent cutaneous diversion),
(2) bladder reconstruction and (3) replacement of the bladder with various intestinal segments.
Objectives
To determine the best way of improving or replacing the function of the lower urinary tract using intestinal segments when the bladder
has to be removed or when it has been rendered useless or dangerous by disease.
Search methods
We searched the Cochrane Incontinence Group Specialised Trials Register (searched 28 October 2011), which contains trials identified
from the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE and CINAHL, and handsearching of journals and
conference proceedings, and the reference lists of relevant articles.
Selection criteria
All randomised or quasi-randomised controlled trials of surgery involving transposition of an intestinal segment into the urinary tract.
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Data collection and analysis
Trials were evaluated for appropriateness for inclusion and for risk of bias by the review authors. Three review authors were involved
in the data extraction. Data were combined in a meta-analysis when appropriate.
Main results
Five trials met the inclusion criteria with a total of 355 participants. These trials addressed only five of the 14 comparisons pre-specified
in the protocol. One trial reported no statistically significant differences in the incidence of upper urinary tract infection, uretero-
intestinal stenosis and renal deterioration in the comparison of continent diversion with conduit diversion. The confidence intervals
were all wide, however, and did not rule out important clinical differences. In a second trial, there was no reported difference in the
incidence of upper urinary tract infection and uretero-intestinal stenosis when conduit diversions were fashioned from either ileum
or colon. A meta-analysis of two trials showed no statistically significant difference in daytime or nocturnal incontinence amongst
participants who were randomised to ileocolonic/ileocaecal segment bladder replacement compared to an ileal bladder replacement.
However, one small trial suggested that bladder replacement using an ileal segment compared to using an ileocolonic segment may
be better in terms of lower rates of nocturnal incontinence. There were no differences in the incidence of dilatation of upper tract,
daytime urinary incontinence or wound infection using different intestinal segments for bladder replacement. However the data were
reported for ’renal units’, but not in a form that allowed appropriate patient-based paired analyses. No statistically significant difference
was found in the incidence of renal scarring between anti-refluxing versus freely refluxing uretero-intestinal anastomotic techniques in
conduit diversions and bladder replacement groups. Again, the outcome data were not reported as paired analysis or in form to carry
out paired analysis.
Authors’ conclusions
The evidence from the included trials was very limited. Only five studies met the inclusion criteria; these were small, of moderate
or poor methodological quality, and reported few of the pre-selected outcome measures. This review did not find any evidence that
bladder replacement (orthotopic or continent diversion) was better than conduit diversion following cystectomy for cancer. There
was no evidence to suggest that bladder reconstruction was better than conduit diversion for benign disease. The clinical significance
of data from one small trial suggesting that bladder replacement using an ileal segment compared to using an ileocolonic segment is
better in terms of lower rates of nocturnal incontinence is uncertain. The small amount of usable evidence for this review suggests that
collaborative multi centre studies should be organised, using random allocation where possible.
P L A I N L A N G U A G E S U M M A R Y
Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence following
bladder surgery
The normal urinary bladder is a hollow muscular organ that lies deep in the pelvis. It functions through the balanced activity of many
inter-related nerves and muscles that contain or empty urine as needed. If the bladder has been damaged by disease, surgery can be
performed to divert the urine from the bladder (urinary diversion), to reconstruct the bladder or to replace the bladder with intestinal
segments. The review did not find enough evidence from trials to show which surgical options are the most effective. One small trial
suggested that the ileum bowel segment (small bowel) may be better compared to ileocolonic bowel segment (combination of small
and large bowel) for night time incontinence. More research is needed to determine the most effective surgical methods for urinary
diversion, reconstruction or replacement of the urinary bladder that has been damaged by disease.
B A C K G R O U N D
For over a century, urological surgeons have grappled with the
problem of how to improve or replace the function of the lower
urinary tract when it has been rendered useless or dangerous by
disease.
The lower urinary tract consists of the bladder (reservoir), urethra
(conduit) and sphincters (continent mechanism). The normal uri-
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nary bladder is a hollowmuscular organ that lies deep in the pelvis.
It functions through the balanced activity of many inter-related
neural and muscular structures. Co-ordinated reflex activity of the
detrusor muscle and sphincter complex results in a low-pressure
reservoir for urine storage that is capable of complete emptying
through the urethra, in addition to allowing continence between
voids. The ideal bladder replacement would have the following
attributes:
(1) good volume with low pressure storage;
(2) socially acceptable voluntary and complete efficient emptying
either by valsalva or clean intermittent self catheterisation (CISC);
(3) allows continence between voids;
(4) protection of upper urinary tract (kidney and ureter);
(5) avoidance of harmful long term sequelae and optimise quality
of life;
(6) cost effective.
When the bladder has to be removed or when it has been rendered
useless or dangerous by disease, the solutions have ranged from:
(a) urinary diversion:
(i) conduit diversion (the creation of various intestinal conduits
to the skin);
(ii) continent diversion (simple drainage by anastomosis (surgical
joining) of the ureters to the colon (ureterosigmoidostomy), which
include either a rectal reservoir or continent cutaneous diversion);
(b) the reconstruction of the bladder; or
(c) replacement of the bladder with various intestinal segments.
Terminology
We used the term continent diversion strictly to mean conti-
nent cutaneous diversion, uretero-sigmoidostomy and the newer
variants of uretero-sigmoidostomy. By bladder reconstruction we
meant that the native bladder was surgically manipulated to im-
prove its function. Whilst for the purpose of this review we only
assessed the surgical procedures that made use of intestinal seg-
ments as part of the bladder reconstruction (e.g. augmentation
cystoplasty or enterocystoplasty), we acknowledge that the true
meaning also includes other procedures like detrusor myectomy
or auto-augmentation. The terms bladder replacement or substi-
tution were used to mean that the native bladder was removed
completely and a new reservoir created, positioned where the na-
tive bladder used to be and connected to the native urethra, there-
fore allowing patients to void in a natural way. The term “undi-
version” was taken to mean conversion from conduit to bladder
reconstruction, bladder replacement or continent diversion.
Principles underlying the various surgical options are outlined be-
low:
a) Urinary diversion
Conduit (incontinent) diversion
The ureters are disconnected from the native bladder and anasto-
mosed to the proximal end of a 15 cm (approximately) isolated
bowel segment (Bricker 1950). The distal end of the bowel seg-
ment is brought out through the abdominal wall as a stoma to
which a bag is attached to collect the draining urine. Whilst tradi-
tionally, small intestine is used, large intestine has also been used.
Continent diversion
i) Continent cutaneous diversion
This involves the creation of a lowpressure reservoir of good capac-
ity using a detubularised intestinal segment technique pioneered
by Kock et al (Kock 1982). The disconnected ureters are anasto-
mosed to the reservoir. Various techniques can be used to main-
tain continence. In the nipple valve principle, the valve protrudes
into the reservoir cavity and as the reservoir fills, the valve is com-
pressed preventing incontinence. The flap valve technique relies
on the proximal segment of the continence channel running on
the inner wall of the reservoir. As the reservoir fills, the channel is
compressed preventing incontinence. An alternative approach is
to use a flap valve. The most popular type of flap valve is the ap-
pendix implanted into the reservoir (Mitrofanoff principle). The
distal end of the continence channel is brought out as a stoma
through the abdominal wall for clean intermittent self-catheter-
isation, thus avoiding use of a stoma bag. The main difference
compared to the conduit diversion is that the reservoir is internal
rather than external (stoma bag use).
ii) Rectal reservoir
Classical ureterosigmoidostomy has been replaced with the more
modern low-pressure rectal reservoir. The ureters are anastomosed
to the rectum which acts as the reservoir and the anal sphincter
employed to maintain continence. In some of these techniques,
attempts are made to limit the admixture of urine and faeces and,
in some cases, this involves disconnecting the sigmoid colon and
either bringing it out as a stoma or, more commonly, through the
perineum. By doing the latter, both urinary and bowel control can
be maintained. Some techniques use proximal intussusception of
the sigmoid colon to confine urine to a smaller surface area hence
limiting the metabolic disturbance seen in the classical ureterosig-
moidostomy (Kock 1988).
3Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following
cystectomy (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
b) Bladder reconstruction
Augmentation cystoplasty/enterocystoplasty
Mikulicz in 1899 (Mikulicz 1899) was the first to describe us-
ing a segment of ileum to perform an augmentation onto a coro-
nally bisected human bladder. Clam enterocystoplasty described
by Bramble (Bramble 1982; Bramble 1990) was therefore a mod-
ified technique and involved the incorporation of a detubularised
isolated bowel segment onto a near-complete sagittally bisected
bladder.
c) Bladder replacement or substitution
Orthotopic neobladder
In orthotopic (in the normal or usual place) bladder replacement,
creation of the neobladder and its anastomosis to the disconnected
ureters uses the same principles as in continent cutaneous diversion
surgery. For the outlet, the reservoir is anastomosed to the native
urethra and therefore patients can maintain continence (if the
native sphincter mechanism is still intact) and void via their native
urethra. If patients encounter difficulty emptying the reservoir,
they can perform clean intermittent self-catheterisation (CISC).
The proportion needing to perform CISC following orthotopic
reconstruction varied in different series from 0% to 70%. The
remaining patients learnt to recognise when the neo-bladder was
full and strained to void. The technique of CISC is well tolerated
(Lapides 1972; Webb 1990).
Regardless of the bowel segment used to augment or create a neo-
bladder, results were relatively satisfactory if the bowel was de-
tubularised and a spherical-shaped reservoir created. Contractile
activity thereafter became discontinuous and disorganised reduc-
ing the pressure within the reconstructed bladder hence decreasing
the chances of post-operative incontinence. Critical to the success
of any urinary diversion is the creation of a safe uretero-intestinal
anastomosis that is prone neither to leakage nor stricture. As a
freely refluxing anastomosis could lead to upper tract dilatation
in the presence of phasic intestinal contractions (Neal 1989), the
alternative historically, was the use of an anti-reflux anastomotic
technique. However, this carried a higher risk of upper tract ob-
struction because of stricture formation. More recently, Stüder et
al (Studer 1996) reported that the deleterious effect of reflux could
be eliminated by implantation of the ureters into an afferent, tubu-
lar, iso-peristaltic 20 cm length of ileum without the use of an
anti-reflux anastomotic technique. There is therefore a dilemma
between the use of a refluxing anastomosis with a reportedly lower
stricture rate, but with the potential to cause renal damage and
the use of an anti-refluxing anastomosis with a reportedly higher
stricture rate, but with less potential to cause renal damage (if not
stenotic).
Reasons for urinary diversion or bladder
reconstruction /replacement
Themain indications for performing a urinary diversion or a blad-
der reconstruction/replacement using transposed intestinal seg-
ments are bladder cancer, neurogenic bladder dysfunction, idio-
pathic detrusor overactivity and chronic inflammatory conditions
(such as interstitial cystitis, tuberculosis, schistosomiasis and post-
radiation bladder contraction).
Bladder cancer
People with muscle invasive bladder cancer require aggressive
treatment which usually means either radiotherapy or cystectomy
(surgery to remove the bladder) with or without chemotherapy.
If the decision is radical cystectomy, the choice of how to replace
lower urinary tract function rests between conduit diversion, blad-
der replacement or continent diversion.
Neurogenic bladder dysfunction
This may result from congenital or acquired disorders (e.g. neural
tube defect or spinal cord injured patients) and can present clini-
cally in a number of ways including frequency, urgency, urinary in-
continence, intermittency, urinary retention or urinary tract infec-
tions. Dysfunction of the lower urinary tract may result in vesico-
ureteric reflux or impaired drainage of the ureters resulting in hy-
dronephrosis. Before the era of clean intermittent self-catheterisa-
tion (CISC), many patients with neurogenic bladder dysfunction
had their urine diverted by means of an ileal conduit when con-
servative measures failed. Nowadays, however, the options would
include either bladder reconstruction, replacement or continent
diversion. The main indications for such surgery in this group
of patients include intractable incontinence, deteriorating renal
function and high bladder pressures.
Detrusor overactivity
Detrusor overactivity is characterised by detrusor (bladder wall
muscle) contractions either spontaneously or on provocation dur-
ing the filling phase while the patient is attempting to inhibit mic-
turition. The urological management of people with detrusor in-
stability (DI) is difficult (Couillard 1995). Patients with severe de-
trusor instability are distressed by urinary incontinence and often
desperate for treatment. The majority of patients with detrusor
instability are treated conservatively using drug therapy, transcuta-
neous electrical nerve stimulation or S3-neuromodulation. If con-
servative measures fail however, surgery which may involve trans-
position of intestinal segments into the urinary tract (e.g. Clam en-
terocystoplasty) can provide effective treatment for some patients
(George 1991; Kockelbergh 1991; Lewis 1990; Sethia 1991).
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Chronic inflammatory disorders of the bladder
(a) Interstitial Cystitis
Idiopathic interstitial cystitis is a chronic inflammatory bladder
disorder of unknown aetiology (Hanno 1990; Thompson 1996).
In most patients conservative treatments produce only temporary
relief and in some there is progressive deterioration which often
culminates in a request for surgical treatment. The options range
from ileal conduit diversion to orthotopic bladder replacement,
but choosing patients who will benefit from surgery is difficult.
(b) Tuberculosis
The World Health Organisation estimates that there are approxi-
mately 10 million new cases of all forms of tuberculosis each year
predominantly affecting people living in developing countries. It
is estimated that between 8 to 20 % of patients with pulmonary
tuberculosis have Mycobacterium tuberculosis in their urine. Tu-
berculosis can affect the entire genito-urinary tract.When it affects
the bladder, it may result in intolerable frequency, pain, urgency
and haematuria. The bladder can become small, contracted and
incapable of holding more than 100 ml of urine, which may lead
to treatment by augmentation cystoplasty.
The purpose of the review was to provide an easily accessible, peri-
odically updated, comprehensive systematic review which would
not only help to identify optimal practice, but also highlight gaps
in the evidence base.
O B J E C T I V E S
To determine the best way of improving or replacing the func-
tion of the lower urinary tract using intestinal segments when the
bladder has to be removed or when it had been rendered useless
or dangerous by disease.
The following comparisons were pre-stated:
(1) whether continent diversion is better than conduit diversion;
(2) whether bladder reconstruction is better than conduit diver-
sion;
(3) whether bladder reconstruction is better than continent diver-
sion;
(4) whether bladder reconstruction is better than bladder replace-
ment;
(5) whether bladder replacement is better than conduit diversion;
(6) whether bladder replacement is better than continent diver-
sion;
(7) whether one formof continent diversion is better than another;
(8) whether use of an intestinal segment from one part of the gut
for bladder reconstruction is better than a segment from another
part;
(9) whether use of an intestinal segment from one part of the gut
for bladder replacement is better than a segment from another
part;
(10) whether use of an intestinal segment from one part of the gut
for continent cutaneous diversion is better than a segment from
another part;
(11) whether use of an intestinal segment from one part of the gut
for conduit diversion is better than a segment from another part;
(12) whether the use of an anti-reflux uretero-intestinal anasto-
motic technique is better than a freely refluxing anastomosis in
bladder replacement;
(13) whether the use of an anti-reflux uretero-intestinal anasto-
motic technique is better than a freely refluxing anastomosis in
continent diversion;
(14) whether the use of an anti-reflux uretero-intestinal anasto-
motic technique is better than a freely refluxing anastomosis in
conduit diversion.
Whilst we understood that there were important issues of choice
within these broad groups, which deserved a review of the evidence
in their own right, for instance, choice of continencemechanism in
bladder replacement or the choice of outlet in continent cutaneous
diversion, these were not considered in this review.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised or quasi-randomised controlled trials of surgery
involving transposition of an intestinal segment into the urinary
tract.
Types of participants
All patients that underwent surgery involving transposition of an
intestinal segment to improve or replace lower urinary tract func-
tion. No exclusions were based on age or sex.
Types of interventions
Eligible studies would include one or more of the following:
• Conduit diversion
• Continent diversion
• Bladder reconstruction (only those using intestinal
segments)
• Bladder replacement / substitution
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Types of outcome measures
Quality of life
• General measures of health status - Short Form 36 (Ware
1993)
• Disease specific measures of quality of life
• Other measures of patient satisfaction (including sexual
function)
Patient symptoms
• Lower urinary tract infection (frequency and hospital
admissions)
• Upper urinary tract infection (frequency and hospital
admissions)
• Clean intermittent self catheterisation rates
• Mucus
- catheter blockage
- urostomy pouch blockage
- patient complaint
• Bowel dysfunction
- diarrhoea
- faecal urgency
- faecal incontinence
- flatus leakage
- constipation
• Urinary incontinence (daytime and night-time)
• Odour
• Stoma stenosis / hernia
Clinical end points
• Need for re-operation
• Operative complications
• Post-operative morbidity / mortality
• Length of operation
• Length of hospital stay
• Anastomotic leak (bowel or bladder)
Health economic measures
• Cost of the alternative managements
• Cost consequence of effects of management
• Formal cost-effectiveness analyses
Physiological/radiological measures
• Active reflux
• Upper tract dilatation
• Urinary stones (lower and upper)
• Bone disease
• Vitamin B12 deficiency
• Metabolic acidosis / alkalosis
• Bile acid malabsorption
• Hepatic encephalopathy
• Deterioration of glomerular filtration rate
• Renal failure
• Renal scarring
Urodynamic measures
Endoscopic assessment
• Cancer development
Search methods for identification of studies
We did not impose any language or other restrictions on any of
these searches detailed below.
Electronic searches
This review has drawn on the search strategy developed for the
Incontinence Review Group.We identified relevant trials from the
Group’s Specialised Register of controlled trials which is described
under the Incontinence Group’s module in The Cochrane Library.
The register contains trials identified fromMEDLINE,CINAHL,
The Cochrane Central Register of Controlled Trials (CENTRAL)
and handsearching of journals and conference proceedings. The
Incontinence Group’s register was last searched on 28 October
2011 using the Group’s own keyword system, the search terms
used were:
({design.cct.*} OR {design.rct.*})
AND
topic.urine*
AND
({intvent.surg.bladdistension.} OR {intvent.surg.cystoscopy.} OR
{intvent.surg.diathermy.} OR {intvent.surg.diversion.*} OR
{intvent.surg.neurological.} OR {intvent.surg.self-dilatation.} OR
{intvent.surg.sphincterectomy.} OR
{intvent.surg.sphincterotomy.} OR {intvent.surg.urethrotomy.}
OR {intvent.surg.cryosurgery.} OR {intvent.surg.gynaecology.})
(All searches were of the keyword field of Reference Manager 12,
Thomson Reuters).
The trials in the Incontinence Group’s Specialised Register are also
partially contained in CENTRAL.
For the previous version of this review extra specific searches were
performed. These are detailed in Appendix 1, including the search
terms used.
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Searching other resources
The reference lists of relevant articles were searched for other pos-
sible relevant trials.
Data collection and analysis
Selection of studies
The reports of all possibly eligible studies were evaluated for risk
of bias and appropriateness for inclusion by the reviewers without
prior consideration of the results. Any disagreements were resolved
by discussion. Where these were not resolved, arbitration rested
with a third person. Studies were excluded if they were not ran-
domised or quasi-randomised trials for patients with intractable
incontinence or following cystectomy. Excluded studies were listed
with reasons for their exclusion.
Data extraction and management
Data extraction were undertaken independently by the reviewers
and cross checked. Where data may have been collected but not
reported, clarification was sought from the trialists. Included trial
data was processed as described in the Cochrane Collaboration
Handbook (Higgins 2011). Information on the characteristics of
participants and interventions as well as on the pre-specified out-
come measures was extracted for each trial.
Assessment of risk of bias in included studies
Assessment of risk of bias was undertaken by each reviewer us-
ing the Cochrane Collaboration’s Risk of Bias tool which in-
cluded quality of random allocation and concealment, description
of dropouts and withdrawals, analysis by intention to treat, and
’blinding’ during treatment and at outcome assessment.
Measures of treatment effect
For dichotomous outcomes we related the numbers reporting an
outcome to the numbers at risk in each group to derive a risk
ratio, and for continuous variables we used means and standard
deviations to derive a weighted mean difference, both with 95%
confidence intervals (CIs). The intention had been to undertake
meta-analysis, when appropriate, using a fixed effects model and
exploring differences between trials if significant heterogeneity was
found or appeared obvious from visual inspection of the results.
If appropriate, the results of included studies were combined for
each outcome in a formal meta-analysis to produce an overall
estimate of treatment effect. were derived using a fixed effects
model and for continuous data weightedmean differences (WMD
- weighted by the inverse of the variance)
Assessment of heterogeneity
Heterogeneity amongst studies was explored by means of a visual
inspection of the graphical plot of the results and formally by the
Chi-squared test and I square test. In case of considerable statistical
heterogeneity (e.g. significance level less than 0.10) with no clear
explanation, the reviewers adopted the following options:
• to exclude the results of studies that contributed most
variation and repeat the analysis (recalculating the summary
measure of effect and the heterogeneity statistics for the
remaining studies) until no heterogeneity is present;
• to use both a fixed and a random effects model to see if they
give substantially different results.
Data synthesis
If appropriate, the results of included studies were combined for
each outcome in a formal meta-analysis to produce an overall
estimate of treatment effect using a fixed effects model
Sensitivity analysis
Although trials with participants of different aetiologies for the
purpose of analysis were grouped together, we recognised that
the outcomes may have been different. For instance, mortality in
patients having surgery because of bladder cancer would have been
expected to be different to that for benign disease. We therefore
planned to perform sensitivity analysis for such patient groups.
However, in the event this was not possible because no data were
available on mortality.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of ongoing studies.
Results of the search
For this review 51 records were screened and 35 full text articles
were retrieved; of these 25 reports were excluded with reasons
given in the Characteristics of excluded studies table. Ten reports
of five studies met the eligibility criteria and were included (Chen
2009; Khafagy 2006; Kristjansson 1995; Shaaban 2006; Studer
1996). Please see the PRISMA diagram in Figure 1 for the flow of
literature through the assessment process.
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Figure 1. PRISMA study flow diagram.
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Included studies
The five included trials had a total of 355 participants (Chen 2009;
Khafagy 2006; Kristjansson 1995; Shaaban 2006; Studer 1996).
All were randomised trials. For two trials (Kristjansson 1995;
Studer 1996) the report of longer-term follow-up was considered
as the primary report by the reviewers. The first of these two trials
(Studer 1996)was originally carried out in 1991 (Studer 1991) and
the second (Kristjansson 1995a) in 1989 (Mansson 1989). This
trial (Mansson 1989), had essentially one subsequent follow-up
report with different outcome measures reported in two papers in
the same volume of the British Journal of Urology. These two fol-
low-up papers had the same first author (Kristjansson 1995). The
first paper, which had the same outcome measures (renal function,
uretero-intestinal strictures and incidence of urinary tract infec-
tions) as the original report (Mansson 1989), was assigned as the
primary reference (Kristjansson 1995a) as it had the longest follow-
up on the original group of patients studied. The second paper by
Kristjansson et al (Kristjansson 1995b) reported on the incidence
of renal scarring (determined by renal scintigraphy) and location
of bacteriuria (detected by urine sampling from the conduit and
direct renal pelvis percutaneous aspiration). Whilst Studer refers
to the afferent ileal tubular segment as a dynamic anti-reflux device
under low pressure conditions (Studer 1996), the anastomosis of
the ureters to the ileal segment is that of a freely refluxing anasto-
mosis and for the purposes of this review is classified as such.
Two trials (Khafagy 2006; Chen 2009) compared the outcomes of
twodifferent types of bowel segments used for bladder replacement
and Shaaban et al (Shaaban 2006) reported outcomes of refluxing
and anti-refluxing techniques of uretero-enteric anastomosis in
bladder replacement surgery.
Excluded studies
Twenty five studies were excluded. Eleven were excluded be-
cause they did not fulfil the criteria of the review (Davidsson
1996; Degen 1997; El 2002; Ghoneim 1988; Lampel 1995;
Lightfoot 2007; Mansson 2004; Mattei 2008; Morey 2006;
Osman 2004; Osman 2009; Shaaban 1992; Shokeir 1995; Thakar
1998; Vakalopoulos 2011).Nine studies were excluded principally
because they were not prospective randomised trials (Bassi 1996;
Boyd 1987; Brough 1998; DeCarli 1997; Kolettis 1996;Mansson
1997; Okada 1989; Speakman 1989; Studer 1997). One further
study (Ghoneim 1981) appeared to fulfil the criteria of the review,
but was not included as the authors did not report the number
of patients in each treatment group. This omission did not allow
analysis of the data presented. This trial compared refluxing versus
non-refluxing techniques in a continent diversion (ureterosigmoi-
dostomy) looking at outcome measures of upper tract dilatation
and incidence of day / night time incontinence. The reviewers are
attempting to contact the authors about providing further data,
and will update the review accordingly if successful.
Comparisons on interventions and outcome
measures
The first included trial (Studer 1996) compared an anti-reflux
mechanism (anti-reflux nipple) against a refluxing mechanism (af-
ferent ileal tubular segment). Outcome measures that this trial
looked at included number of patients with pyelonephritis (no
incidence of hospitalisation mentioned), number with urinary in-
continence, number with uretero-intestinal stenosis and physio-
logical / radiological measures such as the incidence of active re-
flux, upper tract dilatation, lower urinary stones, vitamin B12 de-
ficiency and increase in kidney size.
Kristjamsson et al (Kristjansson 1995) compared (1) Continent
diversion vs Conduit diversion, (2) Anti-reflux mechanism vs re-
fluxing mechanism for the conduit diversion and (3) One segment
(ileal) vs another (colon) for conduit diversion.Outcomemeasures
for the first comparison (continent vs conduit diversion) included
the number of patients with upper urinary tract infection (no inci-
dence of hospitalisation mentioned), number with uretero-intesti-
nal stenosis and physiological / radiological measures such as the
glomerular filtration rate and presence of renal scarring as mea-
sured by renal scintigraphy. The outcome measures for the second
comparison (anti-reflux vs reflux for conduit diversion) included
physiological / radiological measures such as the presence of re-
nal scarring as measured by renal scintigraphy. Finally, the out-
come measure for the third comparison (one segment vs another
for conduit diversion) included the number of patients with up-
per urinary tract infection (no hospitalisation mentioned), num-
ber with uretero-intestinal stenosis and physiological / radiologi-
cal measures such as the glomerular filtration rate and presence of
renal scarring as determined by renal scintigraphy.
Khafagy and Chen (Chen 2009; Khafagy 2006) compared the
outcomes of two different types of bowel segments used in blad-
der replacement. Khafagy (Khafagy 2006) compared ileocaecal
with an ileal segment (Studer technique) and Chen (Chen 2009)
compared ileocolonic (Le Bag technique) with an ileal segment.
Le Bag technique used in the Chen (Chen 2009) study used a
freely refluxing Bricker anastomosis where as in the Khafagy trial
(Khafagy 2006) the ileocaecal procedure was non-refluxing. Both
trials included outcomes measures on early complications (urinary
leakage, wound infections etc.) urinary incontinence; serum bio-
chemistry and radiological changes of the upper tract as seen on
intravenous urograms.
Shaaban et al (Shaaban 2006) compared outcomes of refluxing
and anti-refluxing techniques of uretero-enteric anastomosis in
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patients with bladder replacement. Renal units ( left or right) were
randomised to techniques in the same patient. Randomisation was
carried out for the technique and not for the patients.Outcomes of
interest in this study were: early complications; dilatation of upper
tract ( including due to strictures); follow-up glomerular filtration
rates; and requirement of secondary surgical interventions.
Participants and sample characteristics
Studer et al (Studer 1996) had a total number of 70 participants
with 35 allocated to the group with the anti-reflux nipple mech-
anism and 35 to the remaining group with the refluxing mech-
anism (afferent ileal tubular segment). All the trial patients were
male with a median age of 66.6 years in the anti-reflux nipple
mechanism group and 63.8 years in the afferent ileal tubular seg-
ment group. The reported median follow-up was 57 months for
the group with the anti-reflux nipple mechanism and 45 months
for the group with the afferent ileal tubular segment. There was no
specific mention of the inclusion criteria of patients into the trial,
although it was reported that a proportion of the patients under-
went radical cystectomy and subsequent bladder replacement for
bladder cancer.
Kristjansson et al (Kristjansson 1995) originally had 94 partici-
pants in their trial as reported in 1989, with 38 patients prospec-
tively randomised to have formation of ileal conduit, 30 patients
had formation of colonic conduit and the remaining 26 patients
had formation of a continent caecal reservoir. The authors re-
ported that only 56 patients were evaluable at the end of the study
period with 38 unevaluable patients. No reasons were given as
to why these 38 patients were not evaluable. Therefore, the final
numbers for the purposes of evaluation were: 18 patients for the
ileal conduit group, 20 patients for the colonic conduit group and
18 patients for the continent caecal reservoir group. There were
43 male patients and 13 female patients. The reported mean age
was 60 years for both the ileal conduit and colonic conduit group.
The reported mean age for the caecal reservoir group was 50 years.
The reported mean follow-up was 121 months for the ileal con-
duit group, 117 months for the colonic conduit group and 132
months for the continent caecal reservoir group. Of the original
94 patients, 88 patients underwent radical cystectomy and urinary
diversion whereas the remaining 6 patients had simple cystectomy
and urinary diversion for neurogenic bladder dysfunction. The
inclusion criteria included invasive bladder cancer and neurogenic
bladder dysfunction.
Shaaban et al (Shaaban 2006) had 60 patients in their study. A
mean follow-up of 23 months was available for 53 patients. They
were generally healthy with no major co-morbidity and all were
undergoing ileal bladder replacement.
Khafagy et al (Khafagy 2006) randomised 60 patients into two
groups depending on the type of bowel segment used for bladder
replacement. Group one patients had ileal neobladder reconstruc-
tion and group two patients had ileocaecal neobladder reconstruc-
tion following radical cystectomy. All participants had undergone
radical cystectomy for muscle invasive bladder cancer.
One trial (Chen 2009) included 71 male patients randomised to
ileocolonic segment (Le Bag) or ileal segment (Studer technique).
Urodynamic parameters and continence rates were measured at 6
months.
Risk of bias in included studies
Allocation
All the included trials (Chen 2009; Khafagy 2006; Kristjansson
1995; Shaaban 2006; Studer 1996) were stated to be randomised
trials. However there were no further details provided about the
methods of randomisation or concealment.
Blinding
There were no reports of how the authors in the trials attempted
to limit treatment and outcome assessment bias by ensuring that
both patients and assessors were blinded to the initial selection,
treatment and subsequent assessment of trial results.
Incomplete outcome data
In two trials (Khafagy 2006; Studer 1996), there were no reported
drop-outs or losses to follow-up. However, Studer et al (Studer
1996) reported 22 patient deaths were reported due to progressive
bladder cancer, with no reports of the number of deaths in each
study arm. Kristjansson et al (Kristjansson 1995), originally had
94 patients but only reported on 56 patients. The authors failed
to state the reasons as to why 38 patients were not evaluable. It
was unknown whether these 38 patients had dropped-out from
the trial, were lost to follow-up or had died. There were no reasons
reported for the loss of follow-up in one trial (Shaaban 2006).
There was a differential dropout in the Chen trial (Chen 2009),
90 patients were randomised, 85 accepted their assigned randomi-
sation. In the ileocolonic group 42 patients underwent the opera-
tion 33 had complete follow-up at 6 months. In ileal neobladder
43 underwent operation 38 had complete follow-up.
Effects of interventions
Data obtained from the included trials (Chen 2009; Studer 1996;
Shaaban 2006; Khafagy 2006; Kristjansson 1995) related to five
of the comparisons: continent diversion vs conduit diversion, one
segment vs another for conduit diversion, one segment vs another
for bladder replacement; anti-refluxuretero-intestinal anastomotic
technique vs freely refluxing for bladder replacement and anti-
reflux uretero-intestinal anastomotic technique vs freely refluxing
for conduit diversion. It was not possible to address the remaining
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9 comparisons as listed above (Objectives). One comparison (hy-
pothesis 12) was addressed by two trials (Shaaban 2006; Studer
1996), but the data could not be combined because the reported
analysis did not take into account the paired nature of the data (re-
nal units within the patients). When the random allocation was to
different sides (renal units) as reported by Shabaan et al (Shaaban
2006), the issue is similar to cross-over trails, where people are
randomised but the analysis is paired on renal units. The issue is
like cluster trial of two units per cluster. The other four hypotheses
were addressed by only single trial.
Hypothesis 1: Whether continent diversion is better
than conduit diversion [see comparison 1].
Only one trial (Kristjansson 1995) provided data for evaluation of
this comparison. In this trial, two types of conduit diversions [ileal
(n =18) and colonic (n =20)] and caecal continent diversion (n= 8)
were used for the treatment of patients. For the statistical analysis,
the combined outcome measures of the ileal and colonic conduit
diversions (n = 38) were compared to the outcome measures of the
caecal continent diversion. There were no statistically significant
differences in the relative risks of upper urinary tract infection,
number with uretero-intestinal stenosis, incidence of glomerular
filtration rate deterioration (of more than 25%) and renal scarring.
The confidence intervals were all wide, however, and did not rule
out clinically important differences.
Hypothesis 9: Whether use of an intestinal segment
from one part of the gut for bladder replacement is
better than a segment from another part [see
comparison 9].
Two trials (Chen 2009;Khafagy 2006) reported on the comparison
between two different bowel segments (ileal and ileocolonic Chen
2009 and ileal and ileocaecal Khafagy 2006) in the treatment of
patients with bladder replacement. Themeta analysis did not show
any difference in daytime incontinence but with wide confidence
intervals. The meta-analysis showed heterogeneity for the noctur-
nal incontinence outcome, hence we used a random effects model.
The combined result of the two trials did not show a statistically
significant result for nocturnal incontinence (RR 0.62: 95% CI
0.13 to 2.87, Analysis 9.2). However, the Chen trial (Chen 2009)
alone did favour the ileal neobladder over the ileocolonic segment
using the “Le Bag” technique which used a freely refluxing tech-
nique (RR 0.35, 95%CI 0.15 to 0.79. The Khafagy trial (Khafagy
2006) used a non-refluxing technique with the ileocaecal segment.
Chen (Chen 2009) measured continence at 6 months postopera-
tively and classified continence as unsatisfactory if the patient used
more than one pad in the day or night. In the ileocolonic group,
one patient developed a fistula from the ileocolonic anastomosis
to the skin and one developed urethral stenosis due to infection. In
the ileal neobladder group, one patient developed stenosis of the
ileoposterior urethral anastomosis and one developed stenosis of
the ileoureteral anastomosis. Analysis of complication data could
not be carried out in case of double counting participants.
In the Khafagy trial (Khafagy 2006) patients who had ileal
neobladder (n = 29) were compared with patients who had ileo-
caecal neobladder (n = 31). Three in each group developed uri-
nary incontinence, three and one wound infection were reported
respectively in the two groups. Data for dilatation of the upper
urinary tract was reported for ’renal units’, but not in a form that
allowed appropriate patient-based analyses (eight units were af-
fected in those allocated to ileal neobladder compared with four
in the ileo-caecal neobladder). The trial reported a similar con-
tinence rate between the two procedures. However, there was a
higher rate of acidosis, infections and high residual urine in the
ileal neobladder group.
Hypothesis 11: Whether use of an intestinal segment
from one part of the gut (ileum) for conduit diversion
is better than a segment from another part (colon)
[see comparison 11].
One trial (Kristjansson 1995) allowed comparison of outcome
measures between two different gut segments (ileal and colon) in
the treatment of patients with conduit diversion. Patients who had
ileal conduit formation (n = 18) were compared with patients who
had colonic conduit formation (n = 20). Data were available for
only two outcome measures. There were no statistically significant
differences in the relative risks of upper urinary tract infection and
uretero-intestinal stenosis. Again, confidence intervals were wide
and compatible with large clinical differences.
Hypothesis 12: Whether the use of an anti-reflux
uretero-intestinal anastomotic technique is better
than a freely refluxing anastomosis in bladder
replacement [see comparison 12].
The trial by Studer et al (Studer 1996) compared an anti-reflux
mechanism (nipple valve) against a freely refluxing mechanism
(afferent ileal tubular segment) in bladder replacement. Data were
available for five outcome measures. There were no statistically
significant differences in respect of four of these: upper urinary
tract infection, daytime incontinence, nighttime incontinence,
and uretero-intestinal anastomotic strictures. Confidence intervals
were all wide and clinically important differences were not ruled
out. There was a marginally statistically significant difference in
the incidence of upper tract dilatation, suggesting a higher rate
after nipple value treatment, but this was based on only 11 cases
and the confidence interval was wide (RR 0.22; 95% CI 0.05 to
0.96, Analysis 12.4).
The trial by Shaaban et al (Shaaban 2006) compared refluxing and
antirefluxing techniques of uretero-enteric anastomosis in differ-
ent renal units for the same patient. Unfortunately they reported
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neither paired analysis nor data in a form to allow paired analysis.
Of the 53 renal units allocated to direct uretero-ileal anastomosis
technique, one was reported to be obstructed compared to be five
amongst those with an anti-refluxive anastomosis. The equivalent
figure for reflux were 44 out of 53 versus 6 out of 63; however all
five of the obstructed anastomoses had reflux after the obstruction
had been corrected, bringing the total of the antireflux group to
11 out of 53. Data on glomerular filtration rates were only re-
ported graphically, but the figure and commentary indicated no
statistically significant difference between the two groups of the
renal units.
Hypothesis 14: Whether the use of an anti-reflux
uretero-intestinal anastomotic technique is better
than a freely refluxing anastomosis in conduit
diversion [see comparison 14].
The trial by Kristjansson et al (Kristjansson 1995b) also compared
an anti-reflux technique and a freely refluxing anastomosis used
in the formation of ileal and colonic conduit diversion. Data were
only available for one outcome, the incidence of renal scarring. The
authors reported renal units affected rather than the number of
patients affected. No statistically significant difference was found
between the two techniques and the confidence intervals were wide
(risk ratio 1.94; 95% CI 0.92 to 4.08); this analysis does not take
into account ’clustering’ due to the paired renal units.
D I S C U S S I O N
There were few randomised trials that addressed the objectives of
the review. From a total of 25 studies that were identified, only
five trials were suitable for data analysis. Data from two trials on
the outcome of upper tracts (Shaaban 2006; Khafagy 2006) was
reported as ’renal units’, not in a form to perform paired analysis.
No data from eligible trials were available to address 9 of the 14
pre-stated comparisons and the data from the five eligible trials
that were considered were very limited. The outcome measures
that were reported did not include a large proportion of the out-
come measures that the reviewers felt were important to the re-
view. It was therefore not possible to comment on a significant
number of outcome measures. In particular, there was lack of data
on outcomemeasures that looked at patient symptoms and patient
quality of life in general. There was lack of data on clinical end
points such as the immediate, medium-term and long-term prob-
lems encountered by patients post-urinary diversion. Trials did
not report on the incidence of cancer development post-urinary
diversion. There was no data regarding health economic measures
such as the cost of alternative management, the costs of effects
of management and formal cost-effectiveness analyses. Some data
on physiological / radiological measures were found, such as the
incidences of active reflux, upper tract dilatation, lower urinary
tract stones, vitamin B12 deficiency, deterioration of glomerular
filtration rate (more than 25% in the trial reported) and renal scar-
ring. However data on the incidences of physiological / radiolog-
ical measures such as upper urinary tract stones, metabolic bone
disease, metabolic acidosis / alkalosis, bile acid malabsorption and
hepatic encephalopathy were not found. The incidence of renal
failure was not specifically reported. One trial (Kristjansson 1995)
reported on the incidence of glomerular filtration rate deteriora-
tion of more than 25%. This is probably important as it suggests
significant and progressive impairment that is likely to lead to dial-
ysis in the future. However, it would have been useful to know
how many of these patients with deterioration in renal function
actually proceeded to dialysis or re-operation.
Where data were available their usefulness was severely limited by
the small sizes of the trials and hence the few participants who
experienced any of the outcomes. The confidence intervals around
all the estimates were wide and important differences could not
be ruled out (or in) with any assurance.
One trial (Khafagy 2006) reported a higher rate of post-void resid-
ual urine and biochemical acidosis in patients with bladder re-
placement using ileal segment of the intestine as compared to
the ileocaecal segment. The arterial pH was measured every three
monthly in both the groups and was reported significantly higher
in the ileal neobladder (mean 7.39 versus 7.41). The clinical sig-
nificance and long-term outcome of this biochemical results were
not stated. There was no differences in the follow-up serum crea-
tinine between the two groups. The results from this trial need to
be interpreted with caution due to small number of participants
and short follow-up of 2 years.
The data on nocturnal incontinence for two studies (Chen 2009;
Khafagy 2006) was conflicting. The small Chen study (Chen
2009) showed a statistically significant result favouring the ileal
neobladder over an ileocolonic bladder whereas the data from the
similar sized Khafagy trial (Khafagy 2006) showed no statistically
significant difference between the ileal neobladder and ileocaecal
bladder. Analysis of urodynamic variables suggested that the pres-
sure rise during artificial bladder filling (compliance) was slightly
higher on average in those patients with ileocolonic neobladder
which may contribute to increased risk of nocturnal incontinence.
All other urodynamic variables including capacity and urethral
closure pressure were similar between the two types of bladder
replacement. The cause and longer term consequences of the in-
creased rate of nocturnal incontinence in patients with ileocolonic
neobladder therefore remain uncertain and require exploration in
further larger studies with longer follow up.
One marginally statistically significant result was found (Studer
1996). This should be interpreted cautiously for the reasons out-
lined above and also because the authors used renal units (Khafagy
2006; Kristjansson 1995; Shaaban 2006; Studer 1996) and not
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actual patient numbers when reporting on the outcome measures
of upper tract dilatation and renal scarring respectively. Because
the kidneys in an individual participant cannot be considered in-
dependent (if one side is affected, it is more likely that the other
side will be affected too), the level of statistical significance is likely
to be spuriously high. Studer et al (Studer 1996) reported that
patients treated with formation of afferent tubular ileal segment
for bladder replacement had significantly less upper tract dilata-
tion when compared to those treated with anti-reflux nipples. The
afferent ileal tubular segment is said to be a dynamic anti-reflux
device under low-pressure conditions. An afferent limb has an in-
herently higher pressure, per square centimetre, when compared
to a larger volume bladder replacement and it is by this intrinsic
property that afferent limbs are thought to work, preventing reflux
into the ureters that are anastomosed proximally to the afferent
limb. It is thought that the longer the afferent limb, the greater
the resistance to reverse flow. It was noted that the authors in this
trial used the terms of upper tract dilatation and obstruction in-
terchangeably when describing their results. It cannot be assumed
that all patients with upper tract dilatation will have clinically sig-
nificant obstruction, or vice versa. It would have been more mean-
ingful for the authors to have perhaps measured the renal function
of these patients with upper tract dilatation and to have reported
on the incidence of such patients progressing on to re-operation
or dialysis. Again, it is unclear as to how clinically significant the
results may be, as a patient with unilateral upper tract dilatation or
renal scarring may conceivably have normal renal function. This
underlines the need for caution when interpreting these results.
It is important to note that broader evidence on the topics of this
review come from non-comparative or non-randomised studies.
These were not considered in this review because of the likelihood
of bias distorting their interpretation. However, in a separate sys-
tematic review (Nabi 2005) of non-randomised studies, the au-
thors concluded that the level and quality of evidence was poor
and added little to the randomised trials. There is clearly a need for
more randomised trials. The commonest condition resulting in
the need for cystectomy and transposing intestinal segments into
the urinary tract in the Western world is advanced bladder cancer.
There were 10,335 new cases of bladder cancer diagnosed in the
UK in 2008 (Office for National Statistics 2002) The condition
and procedures are common enough for a prospective randomised
trial to be possible in addition to having considerable cost im-
plications to the National Health Service every year. Where ran-
domisation of a patient population is not possible or inappropri-
ate, then an alternative robust method of determining outcome
of ’competing’ surgical procedures should be used, for example, a
partially randomised patient preference study or a comprehensive
cohort design.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
One small study found higher rates of nocturnal incontinence
amongst patients having an ileocolonic bladder replacement com-
pared with an ileal bladder replacement. This study was small and
reported fewmethodological details, longer term outcome was not
assessed. This review did not find any evidence that either bladder
replacement or continent diversion was better than conduit diver-
sion, or vice versa. There is clearly an absence of good quality data
in the literature despite the fact that such surgery is commonplace
and has been so formany decades. In conduit diversion, the review
did not find any evidence that using a segment of ileum was any
more advantageous than using a segment of colon, or vice versa
in either bladder replacement or continent diversion. Similarly,
no difference was found in using either freely refluxing or anti-
refluxing techniques for conduit diversion from the available ev-
idence. The data reviewed would appear to suggest that afferent
ileal tubular segment is less likely to cause upper tract dilatation
compared to the anti-reflux nipples, but even this finding should
be interpreted cautiously. Until better evidence becomes available
(see below), practice will continue to be dictated by local patient,
surgeon and cost factors, together with poorly evaluated advances
in surgical technology.
Implications for research
There is a need for more randomised trials comparing different
surgical techniques. Investigators need to look at more compre-
hensive outcome measures particularly emphasising relevant clin-
ical end points as detailed in this review, quality of life issues and
health economic measures. Because relatively small number of pa-
tients are treated in individual centres, this will require multi cen-
tre collaboration. Where randomisation is difficult or inappropri-
ate other approaches, such as partially randomised patient pref-
erence designs or comprehensive cohort studies, should be used.
Given the wide scope of treatment options and the paucity of high
level evidence it would be important to gain consensus amongst
patients, clinicians and health care managers concerning the key
research questions and their relative priority.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Chen 2009
Methods Randomised controlled trial
single centre
Participants Inclusion: bladder cancer (stage T1G3, T2-3NO-NxMo), male sex, no history of ure-
thral trauma or urethral stricture, normal renal function, desire to obtain an orthotopic
neobladder
Exclusion: more than 80 years old, enteritis
101 men enrolled, 11 patients excluded as did not meet inclusion criteria
90patients randomised, 85 accepted their assigned randomisation. Ileal neocolonic group
42 patients underwent the operation 33 had complete follow-up at 6 months. In ileal
neobladder 43 underwent operation 38 had complete follow-up. Remaining patients
were not included in the investigation
Interventions orthotopic ileocolonic versus ileal neobladder
Outcomes Continence evaluations assessed at 6 months post operatively, classified as unsatisfactory
if patient used more than one pad in the day or night. Serum creatinine, urea nitrogen,
serum electrolyte, midstream urine culture, and ultasonography or intravenous urogra-
phy every 3 months for the first year. Urodynamic studies performed at 6 months post-
operatively. Primary end point was continence and urodynamic parameters. Secondary
endpoint rate of complications, renal function, serum electrolyte levels and urine culture
6 months postoperatively
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk not stated
Allocation concealment (selection bias) Unclear risk not stated
Blinding of participants and personnel
(performance bias)
All outcomes
High risk All 90 patients randomised, 85 accepted
their assigned randomisation
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Micturation/continence questionnaire was
administered by a urologist who was inde-
pendent of all the surgical work
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Chen 2009 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk In ileocolonic group 42 patients underwent
the operation and 33 had complete follow
up at 6 months. In the ileal group 43 un-
derwent the operation and 38 had complete
follow up at 6 months. The remaining pa-
tients were not included in the analyses be-
cause they were lost to, or refused, follow
up
Khafagy 2006
Methods Randomised prospective study comparing various outcomes between Ileal and ileocaecal
bladder replacement surgery
Single centre study
Ileal neobladder (studer type reconstruction)
All patients had perineal exercises following surgery
3 monthly follow-up
Participants Inclusion: All patients with muscle invasive disease undergoing radical cystectomy
Excl: Patients with memebranous urethral involvement.
Interventions Group 1: Ileal neobladder (29)
Group 2: Ileocaecal neobladder (31)
Outcomes Urinary leakage
Wound infection
Deep vein thrombosis
Jaundice
Anuria
Urinary incontinence
Serum biochemistry
Upper tract dilatation
Cancer outcomes
Notes No mention of methods of randomisation
Urodynamics studies done on follow-up only in 13 patients (5 in group 1 and 8 in group
2)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk were randomised into two groups
Allocation concealment (selection bias) Unclear risk not stated
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Khafagy 2006 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk not stated
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk not stated
Incomplete outcome data (attrition bias)
All outcomes
Low risk 29 patients Group A, 31 patients Group B
four patients died after surgery, two in each
group
Kristjansson 1995
Methods Randomised prospective study, initially by Mansson, 1989 with 2 subsequent papers
published with longer follow-up: Kristjansson, 1995a (primary reference) and 1995b
Mansson 1989
Mean follow-up: Ileal conduit 67months, colonic conduit 66months and caecal reservoir
62 months
Drop-outs: none
Kristjansson 1995a (primary reference)
Mean follow-up: Ileal conduit 121 months, colonic conduit 117 months and caecal
reservoir 132 months
Drop-outs: Only 56 patients of previous total 94 patients presented, no reason given.
38 drop-outs
Kristjansson 1995b
Mean follow-up: 150 months
Drop-outs: 5 patients for renal scarring study, 4 patients in bacteriuria study (patients
declined to participate)
Participants Incl: invasive bladder carcinoma, radical cystectomy and neurogenic bladder dysfunction
Mansson 1989
n = 94
Sex: 71 male, 23 female
Mean age: Ileal conduit 60 years, colonic conduit 60 years and caecal reservoir 51 years
Kristjansson 1995a (primary reference)
n = 56
Sex: 43 male, 13 female
Mean age: Ileal conduit 60 years, colonic conduit 60 years, caecal reservoir 50 years
Kristjansson 1995b
n (renal scarring) = 32
n (bacteriuria) = 5
n (GFR in renal units with scarring) = 60
Sex: (no mention)
Mean age: (no mention)
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Kristjansson 1995 (Continued)
Interventions I: Ileal conduit diversion - refluxing
II: Ileal conduit diversion - non - refluxing
III: Colonic conduit diversion - refluxing
IV: Colonic conduit diversion - non - refluxing
V: Caecal continent diversion - non - refluxing
Outcomes Mansson 1989
I: Renal function - glomerular filtration rate
II: Ureterointestinal anastomotic strictures
III: Urinary tract infections
Kristjansson 1995a (primary reference)
I: Renal function: glomerular filtration rate
II: Ureterointestinal anastomotic strictures
III: Urinary tract infections
Kristjansson 1995b
I: Renal scarring: Presence and grade (1-3)
II: Bacteriuria: Presence and location
III: GFR in renal units with scarring
Notes Further follow-up presented by Kristjansson in 1995
Kristjansson 1995awas used as the primary study as this had a longer follow-up compared
to Mansson 1989
The outcomes in Kristjansson 1995b of the presence and location of bacteriuria were
not included as the numbers who participated were very small: 3 with ileal conduit and
2 with colonic conduit
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk not stated
Allocation concealment (selection bias) Unclear risk not stated
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk not stated
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk not stated
Incomplete outcome data (attrition bias)
All outcomes
High risk In 10 patients the initial allocation to
colonic conduit was changed to ileal be-
cause of colonic anomalies. To mini-
mize imbalance between the two conduit
groups, each case following an unplanned
ileal diversion received a colonic conduit
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Shaaban 2006
Methods Prospective randomised controlled trial comparing reflux vs. anti-reflux techniques of
uretero-enteric anastomisis during ileal bladder replacement in the same patient.
60 patients ( 53 male and 7 females)
Participants Incl:
Generally healthy patients with no co-morbid conditions were included
Normal upper tract
Similar GFR in both the renal units.
Organ confined disease
Excl:
Positive urethral margins for malignancy
Interventions Refluxing group (Group 1)- 60 renal units
Anti-refluxing group (Group 2)- 60 renal units
Outcomes Peri-operative complications such as urinary leakage
Upper tract dilatation (Including strictures)
Reflux
Glomerular filtration rate
Pyelonephreritis
Surgical interventions
Notes Data of outcomes such as GFR presented in a graph with no tabulation, hence difficult
to analyse.
No mention of method of randomisation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk not stated
Allocation concealment (selection bias) Unclear risk not stated
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk not stated
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk not stated
Incomplete outcome data (attrition bias)
All outcomes
Low risk everyone accounted for
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Studer 1996
Methods Randomised prospective study, with 1 subsequent paper published with longer follow-
up data: Studer 1996 (primary reference)
Studer 1991
Median follow-up: Anti-reflux nipple 36 months, afferent tubular segment 30 months
Drop-outs: Total 60 patients operated on, but data on 40 presented as follow-up was
more than a year in this subgroup. Total 20 drop-outs
Studer 1996 (primary reference)
Median follow-up: Anti-reflux nipples 57 months, afferent tubular segment 45 months
Drop-outs: None
Participants Incl: radical cystectomy, bladder substitution with ileal segment and male patients only
Excl: Patient follow-up less than a year, female patients
Studer 1991
n (anti-reflux nipple) = 20
n (afferent tubular segment) = 20
Sex: All males
Mean age: 63.7 years
Studer 1996 (primary reference)
n (anti-reflux nipple) = 35
n (afferent tubular segment) = 35
Sex: All males
Median age: anti-reflux nipple 66.6 years and afferent tubular segment 63.8 years
Interventions I: Anti-reflux nipple
II: Afferent ileal tubular segment
Outcomes Studer 1991
I: Reflux vs No reflux
II: Urinary continence (day and night)
III: Bacteriuria presence
IV: Serum acidosis
V: Serum B12
VI: Kidney size
Studer 1996 (primary reference)
I: Urinary continence (day and night)
II: Bacteriuria presence
III: Pyelonephritis
IV: Uretero-intestinal strictures requiring re-operation
V: Upper tract dilatation
VI: Functional reserve
VII: Renal function
VIII: Voiding habits
IX: Urinary stones
Notes No mention of disease type in the inclusion criteria of the study. Studer 1996 was used
as the primary study as this had the longest follow-up
Studer 1991
Unclear causes of deaths. 18 deaths from “progressive” disease and 3 deaths from “other”
causes
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Studer 1996 (Continued)
In 3 patients with metabolic acidosis requiring correction, no mention was made of
which treatment group these patients originated from
Studer 1996 (primary reference)
Note 22 deaths from progressive bladder cancer.
Conflicting numbers of pyelonephritis in patients compared to Studer 1991. For the
purposes of analysis, the numbers from the later report; Studer 1996 were included in
the tables
It was not possible to extract data from Fig. 2 of Studer 1996 paper for the purposes of
analysing the incidence of bacteriuria / positive culture
In upper tract dilatation, the numbers used in the final analysis were from Studer 1996.
It should be noted that renal units were used rather than patient numbers
It was not possible to analyse the outcomes of metabolic acidosis, functional reserve,
renal function and voiding habits in both reports as no actual figures were presented
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk not stated
Allocation concealment (selection bias) Unclear risk not stated
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk not stated
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk not stated
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Total 60 patients operated on, but data on
40 presented as follow-up more than a year
in this subgroup. Total 20 drop-outs
Incl. = inclusion criteria
Excl. = exclusion criteria
GFR = Glomerular filtration rate (mls/min)
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Bassi 1996 This was a non-randomised study comparing patients with ileal conduits and ileal continent diversions
Boyd 1987 This was a non-randomised study looking at quality of life issues in patients with either ileal conduits or ileal
continent diversions
Brough 1998 This was a study looking at the incidence of stone formation in paediatric patients who underwent either
enterocystoplasty with continent diversion or augmentation cystoplasty alone. The study was excluded because
the patients were in a prospective cohort without randomisation
Davidsson 1996 This was a randomised prospective trial that looked at outcomes in patients who underwent two different types
of outlet surgery for neo-bladder. Comparisons of outlet surgery outcomes was not a subject of the review
De Carli 1997 This was a non-randomised study that compared two different types of uretero-ileal anastomoses
Degen 1997 This was a prospective non-randomised study of ileocaecal transposition in rectal carcinoma which was not
relevant for the purposes of this review
El 2002 The study has only reported as an abstract. We are waiting to see full publication of the results
Ghoneim 1981 Randomised trial compared refluxing versus non-refluxing techniques in a continent diversion (ureterosigmoi-
dostomy) Results were not reported separately for both groups. Written to authors
Ghoneim 1988 This was a randomised prospective clinical trial that assessed survival in patients with bladder cancer who had
pre-operative radiotherapy vs no pre-operative radiotherapy, which was not the objective of the review
Kolettis 1996 This was a study on a prospective cohort of patients who underwent a particular type of bladder replacement
Lampel 1995 This was a randomised prospective trial that looked at outcomes in patients who underwent two different types
of outlet surgery for neo-bladder. Comparisons of outlet surgery outcomes was not a subject of the review
Lightfoot 2007 A randomised controlled trial. This study reported impact of post-operative intravenous low dose erythromycin
on the postoperative ileus. This was no the subject of review
Mansson 1997 This study looked at the effect of psychosocial intervention on the outcome of 3 different types of urinary
diversion. It was excluded because the groups receiving the different types of surgery was non-randomised
Mansson 2004 This study compared the health related Quality of life assessment using questionnaires between neutral third
party and treating institution personnel. This was not the primary subject of this review
Mattei 2008 Randomised to stenting
Morey 2006 A randomised controlled trial. This study reports the outcomes of various methods of bowel preparation prior
to cystectomy, which was not the subject of the review
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(Continued)
Okada 1989 This study was non-randomised and followed-up three successive groups of patients who underwent modifi-
cations of the nipple valves of their ileal continent diversion
Osman 2004 This trial was prospectively randomised. However the trial looked at outcomes from 2 different types of anti-
reflux techniques, this was not the subject of this review
Osman 2009 Comparison of two different anti reflux techniques
Shaaban 1992 This study was prospectively randomised. However the study looked at outcomes from 2 different types of
anti-reflux valves that were not the subject of the review
Shokeir 1995 not urinary diversion or bladder reconstruction comparing two types of ileal ureter
Speakman 1989 This study was excluded as it was unclear if the treatment arms underwent randomisation prior to selection
Studer 1997 This was a long-term report on a prospective cohort of patients who underwent ileal bladder replacement/
substitute
Thakar 1998 This study looked at the effect of hysterectomy on bladder and bowel. Although prospectively randomised, this
study was excluded because it was not relevant for the purposes of this review
Vakalopoulos 2011 No intestinal segment used for uretero-ureterocutaneostomy
Characteristics of ongoing studies [ordered by study ID]
Skinner 2009
Trial name or title Skinner 2009
Methods Randomised controlled trial
Participants Patients with primary bladder cancer. Male and female
Interventions Two types of ileal neo bladder: the studer pouch and the T-pouch anti refluxing versus freely refluxing
Outcomes Primary end point renal function
Starting date late 2002
Contact information E.C. Skinner, Dept of Urology, Keck USC School of Medicine, Los Angeles
Notes
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D A T A A N D A N A L Y S E S
Comparison 1. Continent diversion versus conduit
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Quality of life 0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Number of patients with lower
urinary tract infection
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.1 not requiring
hospitalisation
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 requiring hospitalisation 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 more than 3 infection per
year
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Number of patients with upper
urinary tract infection
1 56 Risk Ratio (M-H, Fixed, 95% CI) 1.66 [0.38, 7.20]
3.1 not requiring
hospitalisation
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 requiring hospitalisation 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 more than 3 infection per
year
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.4 Number of patients
with pyelonephritis (No
hospitalisation mentioned)
1 56 Risk Ratio (M-H, Fixed, 95% CI) 1.66 [0.38, 7.20]
4 Number requiring CISC 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Number with excess mucus
production
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.1 catheter blockage 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 urostomy pouch blockage 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.3 Number of patients
complaining
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Number of patients with bowel
dysfunction
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.1 diarrhoea 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 faecal urgency 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.3 faecal incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.4 flatus leakage 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.5 constipation 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Number with urinary
incontinence
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.1 Daytime incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.2 Nightime incontinence 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8 Number complaining of odour 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9 Number with uretero-intestinal
stenosis
1 56 Risk Ratio (M-H, Fixed, 95% CI) 0.66 [0.24, 1.80]
10 Number with stoma stenosis 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
11 Number with parastomal
hernia
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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12 Number needing re-operation 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
13 Number with operative
complications
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
14 Number with post operative
morbidity
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
15 Number of post operative
mortality
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
16 Length of operation 0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
17 Length of hospital stay 0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
18 Number with bladder
anastomotic leak
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19 Number with bowel
anastomotic leak
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
20 Cost of alternative management 0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
21 Cost consequence of effects of
management
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
22 Formal cost effectiveness
analyses
0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
23 Physiological/radiological
measures
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
23.1 Active reflux 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
23.2 upper tract dilatation 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
23.3 Upper urinary stones 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
23.4 Lower urinary stones 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
23.5 Metabolic bone disease 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
23.6 vitamin B12 deficiency 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
23.7 Metaboloic acidosis 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
23.8 Metaboloic alkalosis 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
23.9 Bile acid malabsorption 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
23.10 Hepatic encephalopathy 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
23.11 Deterioration of
glomerular filtration rate
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
23.12 Renal failure 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
23.13 Renal scarring 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
24 Number with urodynamic
measures
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
24.1 bladder capacity 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
25 Number developing cancer 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
Comparison 9. One segment versus another in bladder replacement
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Urinary leakage 1 60 Risk Ratio (M-H, Fixed, 95% CI) 1.07 [0.16, 7.10]
2 Incontinence 2 Risk Ratio (M-H, Random, 95% CI) Subtotals only
2.1 Day time incontinence 2 131 Risk Ratio (M-H, Random, 95% CI) 0.86 [0.31, 2.39]
2.2 Night time incontinence 2 131 Risk Ratio (M-H, Random, 95% CI) 0.62 [0.13, 2.87]
3 Wound infection 1 60 Risk Ratio (M-H, Fixed, 95% CI) 3.21 [0.35, 29.11]
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Comparison 11. One segment versus another for conduit diversion
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Number of patients with upper
urinary tract infection
1 38 Risk Ratio (M-H, Fixed, 95% CI) 1.48 [0.38, 5.74]
1.1 not requiring
hospitalisation
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 requiring hospitalisation 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 more than 3 infection per
year
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.4 Number of patients
with pyelonephritis (No
hospitalisation mentioned)
1 38 Risk Ratio (M-H, Fixed, 95% CI) 1.48 [0.38, 5.74]
2 Number with uretero-intestinal
stenosis
1 38 Risk Ratio (M-H, Fixed, 95% CI) 0.83 [0.22, 3.23]
Comparison 12. Anti reflux versus reflux for bladder replacement
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Number of patients with upper
urinary tract infection
1 70 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.10, 1.13]
1.1 not requiring
hospitalisation
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 requiring hospitalisation 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 more than 3 infection per
year
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.4 Number of patients
with pyelonephritis (No
hospitalisation mentioned)
1 70 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.10, 1.13]
2 Number with urinary
incontinence
1 140 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.47, 2.14]
2.1 Daytime incontinence 1 70 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.27, 3.69]
2.2 Nightime incontinence 1 70 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.39, 2.55]
3 Number with uretero-intestinal
stenosis
1 70 Risk Ratio (M-H, Fixed, 95% CI) 2.0 [0.19, 21.06]
4 Physiological/radiological
measures
1 286 Risk Ratio (M-H, Fixed, 95% CI) 0.22 [0.05, 0.96]
4.1 Active reflux 1 40 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 Upper tract dilatation 1 136 Risk Ratio (M-H, Fixed, 95% CI) 0.22 [0.05, 0.96]
4.3 Upper urinary stones 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.4 Lower urinary stones 1 70 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.5 Metabolic bone disease 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.6 vitamin B12 deficiency 1 40 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.7 Metabolic acidosis 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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4.8 Metabolic alkalosis 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.9 Bile acid malabsorption 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.10 Hepatic encephalopathy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.11 Deterioration of
glomerular filtration rate
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.12 Renal failure 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.13 Renal Scarring 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
Comparison 14. Anti reflux versus reflux for conduit diversion
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Physiological/radiological
measures
1 35 Risk Ratio (M-H, Fixed, 95% CI) 1.94 [0.92, 4.08]
1.1 Active reflux 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 Upper tract dilatation 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 Upper urinary stones 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.4 Lower urinary stones 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.5 Metabolic bone disease 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.6 vitamin B12 deficiency 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.7 Metabolic acidosis 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.8 Metaboloic alkalosis 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.9 Bile acid malabsorption 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.10 Hepatic encephalopathy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.11 Deterioration of
glomerular filtration rate
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.12 Renal failure 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.13 Renal scarring 1 35 Risk Ratio (M-H, Fixed, 95% CI) 1.94 [0.92, 4.08]
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Analysis 1.3. Comparison 1 Continent diversion versus conduit, Outcome 3 Number of patients with upper
urinary tract infection.
Review: Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy
Comparison: 1 Continent diversion versus conduit
Outcome: 3 Number of patients with upper urinary tract infection
Study or subgroup Ileal/Colon Conduit Caecal reservoir Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 not requiring hospitalisation
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Ileal/Colon Conduit), 0 (Caecal reservoir)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 requiring hospitalisation
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Ileal/Colon Conduit), 0 (Caecal reservoir)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 more than 3 infection per year
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Ileal/Colon Conduit), 0 (Caecal reservoir)
Heterogeneity: not applicable
Test for overall effect: not applicable
4 Number of patients with pyelonephritis (No hospitalisation mentioned)
Kristjansson 1995 7/38 2/18 100.0 % 1.66 [ 0.38, 7.20 ]
Subtotal (95% CI) 38 18 100.0 % 1.66 [ 0.38, 7.20 ]
Total events: 7 (Ileal/Colon Conduit), 2 (Caecal reservoir)
Heterogeneity: not applicable
Test for overall effect: Z = 0.67 (P = 0.50)
Total (95% CI) 38 18 100.0 % 1.66 [ 0.38, 7.20 ]
Total events: 7 (Ileal/Colon Conduit), 2 (Caecal reservoir)
Heterogeneity: not applicable
Test for overall effect: Z = 0.67 (P = 0.50)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
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Analysis 1.9. Comparison 1 Continent diversion versus conduit, Outcome 9 Number with uretero-intestinal
stenosis.
Review: Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy
Comparison: 1 Continent diversion versus conduit
Outcome: 9 Number with uretero-intestinal stenosis
Study or subgroup Ileal/Colon Conduit Caecal reservoir Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Kristjansson 1995 7/38 5/18 100.0 % 0.66 [ 0.24, 1.80 ]
Total (95% CI) 38 18 100.0 % 0.66 [ 0.24, 1.80 ]
Total events: 7 (Ileal/Colon Conduit), 5 (Caecal reservoir)
Heterogeneity: not applicable
Test for overall effect: Z = 0.80 (P = 0.42)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
Analysis 1.23. Comparison 1 Continent diversion versus conduit, Outcome 23 Physiological/radiological
measures.
Review: Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy
Comparison: 1 Continent diversion versus conduit
Outcome: 23 Physiological/radiological measures
Study or subgroup Ileal/Colon Conduit Caecal reservoir Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Active reflux
2 upper tract dilatation
3 Upper urinary stones
4 Lower urinary stones
5 Metabolic bone disease
6 vitamin B12 deficiency
7 Metaboloic acidosis
8 Metaboloic alkalosis
9 Bile acid malabsorption
10 Hepatic encephalopathy
11 Deterioration of glomerular filtration rate
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
(Continued . . . )
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(. . . Continued)
Study or subgroup Ileal/Colon Conduit Caecal reservoir Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Kristjansson 1995 5/38 5/18 0.47 [ 0.16, 1.43 ]
12 Renal failure
13 Renal scarring
Kristjansson 1995 17/35 16/25 0.76 [ 0.48, 1.19 ]
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
Analysis 9.1. Comparison 9 One segment versus another in bladder replacement, Outcome 1 Urinary
leakage.
Review: Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy
Comparison: 9 One segment versus another in bladder replacement
Outcome: 1 Urinary leakage
Study or subgroup Ileal neobladder Ileocolonic/ileocaecal Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Khafagy 2006 2/29 2/31 100.0 % 1.07 [ 0.16, 7.10 ]
Total (95% CI) 29 31 100.0 % 1.07 [ 0.16, 7.10 ]
Total events: 2 (Ileal neobladder), 2 (Ileocolonic/ileocaecal)
Heterogeneity: not applicable
Test for overall effect: Z = 0.07 (P = 0.94)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
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Analysis 9.2. Comparison 9 One segment versus another in bladder replacement, Outcome 2 Incontinence.
Review: Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy
Comparison: 9 One segment versus another in bladder replacement
Outcome: 2 Incontinence
Study or subgroup Ileal neobladder Ileocolonic/ileocaecal Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Day time incontinence
Chen 2009 2/38 2/33 28.9 % 0.87 [ 0.13, 5.83 ]
Khafagy 2006 4/29 5/31 71.1 % 0.86 [ 0.25, 2.88 ]
Subtotal (95% CI) 67 64 100.0 % 0.86 [ 0.31, 2.39 ]
Total events: 6 (Ileal neobladder), 7 (Ileocolonic/ileocaecal)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.99); I2 =0.0%
Test for overall effect: Z = 0.29 (P = 0.77)
2 Night time incontinence
Chen 2009 6/38 15/33 46.6 % 0.35 [ 0.15, 0.79 ]
Khafagy 2006 26/29 27/31 53.4 % 1.03 [ 0.86, 1.24 ]
Subtotal (95% CI) 67 64 100.0 % 0.62 [ 0.13, 2.87 ]
Total events: 32 (Ileal neobladder), 42 (Ileocolonic/ileocaecal)
Heterogeneity: Tau2 = 1.13; Chi2 = 13.24, df = 1 (P = 0.00027); I2 =92%
Test for overall effect: Z = 0.61 (P = 0.54)
Test for subgroup differences: Chi2 = 0.12, df = 1 (P = 0.73), I2 =0.0%
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
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Analysis 9.3. Comparison 9 One segment versus another in bladder replacement, Outcome 3 Wound
infection.
Review: Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy
Comparison: 9 One segment versus another in bladder replacement
Outcome: 3 Wound infection
Study or subgroup Ileal neobladder Ileocolonic/ileocaecal Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Khafagy 2006 3/29 1/31 100.0 % 3.21 [ 0.35, 29.11 ]
Total (95% CI) 29 31 100.0 % 3.21 [ 0.35, 29.11 ]
Total events: 3 (Ileal neobladder), 1 (Ileocolonic/ileocaecal)
Heterogeneity: not applicable
Test for overall effect: Z = 1.04 (P = 0.30)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
Analysis 11.1. Comparison 11 One segment versus another for conduit diversion, Outcome 1 Number of
patients with upper urinary tract infection.
Review: Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy
Comparison: 11 One segment versus another for conduit diversion
Outcome: 1 Number of patients with upper urinary tract infection
Study or subgroup Ileal conduit Colonic conduit Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 not requiring hospitalisation
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Ileal conduit), 0 (Colonic conduit)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 requiring hospitalisation
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Ileal conduit), 0 (Colonic conduit)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 more than 3 infection per year
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
(Continued . . . )
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(. . . Continued)
Study or subgroup Ileal conduit Colonic conduit Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Ileal conduit), 0 (Colonic conduit)
Heterogeneity: not applicable
Test for overall effect: not applicable
4 Number of patients with pyelonephritis (No hospitalisation mentioned)
Kristjansson 1995 4/18 3/20 100.0 % 1.48 [ 0.38, 5.74 ]
Subtotal (95% CI) 18 20 100.0 % 1.48 [ 0.38, 5.74 ]
Total events: 4 (Ileal conduit), 3 (Colonic conduit)
Heterogeneity: not applicable
Test for overall effect: Z = 0.57 (P = 0.57)
Total (95% CI) 18 20 100.0 % 1.48 [ 0.38, 5.74 ]
Total events: 4 (Ileal conduit), 3 (Colonic conduit)
Heterogeneity: not applicable
Test for overall effect: Z = 0.57 (P = 0.57)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
Analysis 11.2. Comparison 11 One segment versus another for conduit diversion, Outcome 2 Number with
uretero-intestinal stenosis.
Review: Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy
Comparison: 11 One segment versus another for conduit diversion
Outcome: 2 Number with uretero-intestinal stenosis
Study or subgroup Ileal conduit Colonic conduit Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Kristjansson 1995 3/18 4/20 100.0 % 0.83 [ 0.22, 3.23 ]
Total (95% CI) 18 20 100.0 % 0.83 [ 0.22, 3.23 ]
Total events: 3 (Ileal conduit), 4 (Colonic conduit)
Heterogeneity: not applicable
Test for overall effect: Z = 0.26 (P = 0.79)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
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Analysis 12.1. Comparison 12 Anti reflux versus reflux for bladder replacement, Outcome 1 Number of
patients with upper urinary tract infection.
Review: Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy
Comparison: 12 Anti reflux versus reflux for bladder replacement
Outcome: 1 Number of patients with upper urinary tract infection
Study or subgroup Tubular Segment Anti-reflux Nipple Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 not requiring hospitalisation
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Tubular Segment), 0 (Anti-reflux Nipple)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 requiring hospitalisation
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Tubular Segment), 0 (Anti-reflux Nipple)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 more than 3 infection per year
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Tubular Segment), 0 (Anti-reflux Nipple)
Heterogeneity: not applicable
Test for overall effect: not applicable
4 Number of patients with pyelonephritis (No hospitalisation mentioned)
Studer 1996 3/35 9/35 100.0 % 0.33 [ 0.10, 1.13 ]
Subtotal (95% CI) 35 35 100.0 % 0.33 [ 0.10, 1.13 ]
Total events: 3 (Tubular Segment), 9 (Anti-reflux Nipple)
Heterogeneity: not applicable
Test for overall effect: Z = 1.77 (P = 0.078)
Total (95% CI) 35 35 100.0 % 0.33 [ 0.10, 1.13 ]
Total events: 3 (Tubular Segment), 9 (Anti-reflux Nipple)
Heterogeneity: not applicable
Test for overall effect: Z = 1.77 (P = 0.078)
Test for subgroup differences: Not applicable
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Analysis 12.2. Comparison 12 Anti reflux versus reflux for bladder replacement, Outcome 2 Number with
urinary incontinence.
Review: Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy
Comparison: 12 Anti reflux versus reflux for bladder replacement
Outcome: 2 Number with urinary incontinence
Study or subgroup Tubular Segment Anti-reflux nipple Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Daytime incontinence
Studer 1996 4/35 4/35 36.4 % 1.00 [ 0.27, 3.69 ]
Subtotal (95% CI) 35 35 36.4 % 1.00 [ 0.27, 3.69 ]
Total events: 4 (Tubular Segment), 4 (Anti-reflux nipple)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
2 Nightime incontinence
Studer 1996 7/35 7/35 63.6 % 1.00 [ 0.39, 2.55 ]
Subtotal (95% CI) 35 35 63.6 % 1.00 [ 0.39, 2.55 ]
Total events: 7 (Tubular Segment), 7 (Anti-reflux nipple)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
Total (95% CI) 70 70 100.0 % 1.00 [ 0.47, 2.14 ]
Total events: 11 (Tubular Segment), 11 (Anti-reflux nipple)
Heterogeneity: Chi2 = 0.0, df = 1 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.0 (P = 1.0)
Test for subgroup differences: Chi2 = 0.0, df = 1 (P = 1.00), I2 =0.0%
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Analysis 12.3. Comparison 12 Anti reflux versus reflux for bladder replacement, Outcome 3 Number with
uretero-intestinal stenosis.
Review: Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy
Comparison: 12 Anti reflux versus reflux for bladder replacement
Outcome: 3 Number with uretero-intestinal stenosis
Study or subgroup Tubular segment Anti-reflux nipple Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Studer 1996 2/35 1/35 100.0 % 2.00 [ 0.19, 21.06 ]
Total (95% CI) 35 35 100.0 % 2.00 [ 0.19, 21.06 ]
Total events: 2 (Tubular segment), 1 (Anti-reflux nipple)
Heterogeneity: not applicable
Test for overall effect: Z = 0.58 (P = 0.56)
Test for subgroup differences: Not applicable
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Analysis 12.4. Comparison 12 Anti reflux versus reflux for bladder replacement, Outcome 4
Physiological/radiological measures.
Review: Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy
Comparison: 12 Anti reflux versus reflux for bladder replacement
Outcome: 4 Physiological/radiological measures
Study or subgroup Tubular Segment Anti-Reflux Nipple Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Active reflux
Studer 1996 0/20 0/20 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 20 20 0.0 [ 0.0, 0.0 ]
Total events: 0 (Tubular Segment), 0 (Anti-Reflux Nipple)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
2 Upper tract dilatation
Studer 1996 2/69 9/67 0.22 [ 0.05, 0.96 ]
Subtotal (95% CI) 69 67 0.22 [ 0.05, 0.96 ]
Total events: 2 (Tubular Segment), 9 (Anti-Reflux Nipple)
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(. . . Continued)
Study or subgroup Tubular Segment Anti-Reflux Nipple Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Heterogeneity: not applicable
Test for overall effect: Z = 2.01 (P = 0.044)
3 Upper urinary stones
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 0 (Tubular Segment), 0 (Anti-Reflux Nipple)
Heterogeneity: not applicable
Test for overall effect: not applicable
4 Lower urinary stones
Studer 1996 0/35 0/35 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 35 35 0.0 [ 0.0, 0.0 ]
Total events: 0 (Tubular Segment), 0 (Anti-Reflux Nipple)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
5 Metabolic bone disease
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 0 (Tubular Segment), 0 (Anti-Reflux Nipple)
Heterogeneity: not applicable
Test for overall effect: not applicable
6 vitamin B12 deficiency
Studer 1996 0/20 0/20 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 20 20 0.0 [ 0.0, 0.0 ]
Total events: 0 (Tubular Segment), 0 (Anti-Reflux Nipple)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
7 Metabolic acidosis
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 0 (Tubular Segment), 0 (Anti-Reflux Nipple)
Heterogeneity: not applicable
Test for overall effect: not applicable
8 Metabolic alkalosis
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 0 (Tubular Segment), 0 (Anti-Reflux Nipple)
Heterogeneity: not applicable
Test for overall effect: not applicable
9 Bile acid malabsorption
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 0 (Tubular Segment), 0 (Anti-Reflux Nipple)
Heterogeneity: not applicable
Test for overall effect: not applicable
10 Hepatic encephalopathy
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 0 (Tubular Segment), 0 (Anti-Reflux Nipple)
Heterogeneity: not applicable
Test for overall effect: not applicable
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(. . . Continued)
Study or subgroup Tubular Segment Anti-Reflux Nipple Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
11 Deterioration of glomerular filtration rate
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 0 (Tubular Segment), 0 (Anti-Reflux Nipple)
Heterogeneity: not applicable
Test for overall effect: not applicable
12 Renal failure
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 0 (Tubular Segment), 0 (Anti-Reflux Nipple)
Heterogeneity: not applicable
Test for overall effect: not applicable
13 Renal Scarring
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 0 (Tubular Segment), 0 (Anti-Reflux Nipple)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 144 142 0.22 [ 0.05, 0.96 ]
Total events: 2 (Tubular Segment), 9 (Anti-Reflux Nipple)
Heterogeneity: Chi2 = 0.0, df = 0 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 2.01 (P = 0.044)
Test for subgroup differences: Not applicable
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Analysis 14.1. Comparison 14 Anti reflux versus reflux for conduit diversion, Outcome 1
Physiological/radiological measures.
Review: Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy
Comparison: 14 Anti reflux versus reflux for conduit diversion
Outcome: 1 Physiological/radiological measures
Study or subgroup Ileal%colon: Ref Ileal%colon: Non-Ref Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Active reflux
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Ileal%colon: Ref), 0 (Ileal%colon: Non-Ref)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Upper tract dilatation
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Ileal%colon: Ref), 0 (Ileal%colon: Non-Ref)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Upper urinary stones
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Ileal%colon: Ref), 0 (Ileal%colon: Non-Ref)
Heterogeneity: not applicable
Test for overall effect: not applicable
4 Lower urinary stones
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Ileal%colon: Ref), 0 (Ileal%colon: Non-Ref)
Heterogeneity: not applicable
Test for overall effect: not applicable
5 Metabolic bone disease
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Ileal%colon: Ref), 0 (Ileal%colon: Non-Ref)
Heterogeneity: not applicable
Test for overall effect: not applicable
6 vitamin B12 deficiency
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Ileal%colon: Ref), 0 (Ileal%colon: Non-Ref)
Heterogeneity: not applicable
Test for overall effect: not applicable
7 Metabolic acidosis
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Ileal%colon: Ref), 0 (Ileal%colon: Non-Ref)
Heterogeneity: not applicable
Test for overall effect: not applicable
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Study or subgroup Ileal%colon: Ref Ileal%colon: Non-Ref Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
8 Metaboloic alkalosis
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Ileal%colon: Ref), 0 (Ileal%colon: Non-Ref)
Heterogeneity: not applicable
Test for overall effect: not applicable
9 Bile acid malabsorption
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Ileal%colon: Ref), 0 (Ileal%colon: Non-Ref)
Heterogeneity: not applicable
Test for overall effect: not applicable
10 Hepatic encephalopathy
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Ileal%colon: Ref), 0 (Ileal%colon: Non-Ref)
Heterogeneity: not applicable
Test for overall effect: not applicable
11 Deterioration of glomerular filtration rate
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Ileal%colon: Ref), 0 (Ileal%colon: Non-Ref)
Heterogeneity: not applicable
Test for overall effect: not applicable
12 Renal failure
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Ileal%colon: Ref), 0 (Ileal%colon: Non-Ref)
Heterogeneity: not applicable
Test for overall effect: not applicable
13 Renal scarring
Kristjansson 1995 11/17 6/18 100.0 % 1.94 [ 0.92, 4.08 ]
Subtotal (95% CI) 17 18 100.0 % 1.94 [ 0.92, 4.08 ]
Total events: 11 (Ileal%colon: Ref), 6 (Ileal%colon: Non-Ref)
Heterogeneity: not applicable
Test for overall effect: Z = 1.75 (P = 0.080)
Total (95% CI) 17 18 100.0 % 1.94 [ 0.92, 4.08 ]
Total events: 11 (Ileal%colon: Ref), 6 (Ileal%colon: Non-Ref)
Heterogeneity: not applicable
Test for overall effect: Z = 1.75 (P = 0.080)
Test for subgroup differences: Not applicable
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A P P E N D I C E S
Appendix 1. Search methods and terms used for the extra specific searches for this review
For the previous version of this review extra specific searches were performed. These are detailed below, including the search terms used.
• MEDLINE (on Ovid) (years searched: 1966 to Week 3 January 2005) and MEDLINE In Process (on Ovid) (search covered: 31
January 2005) were both searched on 2 February 2005
• CENTRAL was searched on 17 May 2001 (in The Cochrane Library, Issue 2, 2001 on CD-ROM)
• Dissertation Abstracts (on UMI ProQuest Digital Dissertations) was searched on 18 June 2001
MEDLINE (on Ovid) (years searched: 1966 to Week 3 January 2005), MEDLINE In Process (on Ovid)(search covered: 31 January
2005) were both searched on 2 February 2005 using the following search terms combined together using the Boolean operator ’OR’
and then combined using the Boolean operator ’AND’ with the first two parts of the Cochrane ’Highly Sensitive Search Strategy’
(Dickersin 2002):
urinary diversion/
Cystectomy/
Urinary Reservoirs, Continent/
cystectom$.tw.
(conduit$ adj5 (ile$ or urin$ or contine$ or colon$)).tw.
(reservoir$ adj5 (ile$ or urin$ or continen$ or colon$)).tw.
(urin$ adj2 diversion$).tw.
(continen$ adj2 diversion$).tw.
(bladder$ adj2 substitut$).tw.
neobladder$.tw.
cystoplast$.tw.
enterocystoplast$.tw.
(bladder$ adj2 (reconstruct$ or artificial or replac$ or rectal)).tw.
(continen$ adj2 outlet$).tw.
(conduit$ adj2 diversion$).tw.
CENTRAL was searched on 17 May 2001 (in The Cochrane Library, Issue 2, 2001 on CD-ROM) using the following search terms,
combined together using the Boolean operator ’OR’:
URINARY-DIVERSION:ME
CYSTECTOMY*:ME
URINARY-RESERVOIRS-CONTINENT*:ME
CYSTECTOM*
(CONDUIT* near ILE*)
(CONDUIT* near URIN*)
(CONDUIT* near CONTINEN*)
(CONDUIT* near COLON*)
(RESERVOIR* near ILE*)
(RESERVOIR* near URIN*)
(RESERVOIR* near CONTINEN*)
(RESERVOIR* near COLON*)
(URIN* near DIVERSION*)
(CONTINEN* near DIVERSION*)
(BLADDER* near SUBSTITUT*)
NEOBLADDER*
CYSTOPLAST*
ENTEROCYSTOPLAST*
(BLADDER* near RECONSTRUCT*)
(ARTIFICIAL near BLADDER*)
(REPLAC* near BLADDER*)
(RECTAL next BLADDER*)
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(CONTINEN* near OUTLET*)
(CONDUIT* near DIVERSION*)
Dissertation Abstracts (on UMI ProQuest Digital Dissertations) was searched on 18 June 2001 using the search term: urinary
diversion*.
The reference lists of relevant articles were searched for other possible relevant trials.
We did not impose any language or other restrictions on any of these searches.
WH A T ’ S N E W
Last assessed as up-to-date: 7 December 2011.
Date Event Description
22 November 2011 New search has been performed one study added, one ongoing trial
22 November 2011 New citation required but conclusions have not
changed
one study added, one ongoing trial
H I S T O R Y
Protocol first published: Issue 4, 2001
Review first published: Issue 1, 2003
Date Event Description
13 October 2008 Amended Converted to new review format.
19 May 2005 New search has been performed For this update of the review N Ghulam and S Mc-
Clinton assessed the list of 33 potentially relevant trials
and added one extra trial to the list of excluded studies
19 November 2002 New citation required and conclusions have changed Substantive amendment
C O N T R I B U T I O N S O F A U T H O R S
For this update: N Ghulam and S McClinton assessed the list of 33 potentially relevant trials and added one extra trial to the list of
excluded studies.
Original review: J N’Dow and N Dublin wrote the review protocol. S Yong, J N’Dow and J Cody assessed the studies, extracted the
data, analysed the data and wrote the review. R Pickard and D Neal provided critical analysis of the review.
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None known
S O U R C E S O F S U P P O R T
Internal sources
• University of Aberdeen, UK.
External sources
• No sources of support supplied
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Urinary Reservoirs, Continent; Cystectomy; Randomized Controlled Trials as Topic; Urinary Bladder [∗surgery]; Urinary Bladder
Neoplasms [surgery]; Urinary Bladder, Neurogenic [surgery]; Urinary Diversion [∗methods]; Urinary Incontinence [surgery]
MeSH check words
Humans
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